Beneficial effects versus toxicity of medium-chain triacylglycerols in rats with NASH
Authors:
- Charles S. LieberCLCharles S. Lieber
- Leonore M. DeCarliLDLeonore M. DeCarli
- Maria A. LeoMLMaria A. Leo
- Ki M. MakKMKi M. Mak
- Anatoly PonomarenkoAPAnatoly Ponomarenko
- Chaoling RenCRChaoling Ren
- Xiaolei WangXWXiaolei Wang
- 1 February 2008
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 48 (2) , 318-326
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent itMitochondrion, 2006
- Molecular mediators of hepatic steatosis and liver injuryJournal of Clinical Investigation, 2004
- Model of nonalcoholic steatohepatitisThe American Journal of Clinical Nutrition, 2004
- Hepatic Cytochrome P450 2E1 Activity in Nondiabetic Patients With Nonalcoholic SteatohepatitisHepatology, 2003
- Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humansBritish Journal of Clinical Pharmacology, 2003
- Physiological Effects of Medium-Chain Triglycerides: Potential Agents in the Prevention of ObesityThe Journal of Nutrition, 2002
- Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitisHepatology, 1998
- Overfeeding with medium-chain triglyceride diet results in diminished deposition of fatThe American Journal of Clinical Nutrition, 1983
- Hepatic Microsomal Ethanol-oxidizing SystemJournal of Biological Chemistry, 1970
- Difference in Hepatic Metabolism of Long- and Medium-Chain Fatty Acids: the Role of Fatty Acid Chain Length in the Production of the Alcoholic Fatty Liver*Journal of Clinical Investigation, 1967